WORKING WITH US

Harnessing nearly two decades of experience, The Chase Group, Inc. offers standard-setting professional recruitment services in the Life Sciences industry. Because we work exclusively in the substantive areas of global pharmaceuticals, biotechnology, academic medicine and research, non-profits, animal health, diagnostics, medical devices and healthcare communications, our executive recruiters are focused strictly on identifying, targeting and securing the highest quality candidates skilled for these unique markets. By maintaining an extensive network of strategic contacts specific to the Life Sciences industry, The Chase Group can deliver responsive, timely and cost-effective recruitment solutions that meet our clients’ and candidates’ specialized needs.

FINDING A CANDIDATE

Dedication, keen industry insight, individualized service and a competitive spirit unite in The Chase Group’s proprietary approach to recruitment, enabling us to effectively and efficiently secure the high-caliber candidates our clients require.

SECURING A NEW POSITION

Much more than just an executive search firm directory, The Chase Group offers individualized services for both clients and candidates, ensuring that skills, qualifications and personalities are a precise match. For us and for our candidates, each placement signifies more than a job—it may reflect the beginning of an enduring career or the next critical step in one’s professional evolution.

"Find a job you love and never work another day in your life..."

May 27, 2014

ImClone Retains The Chase Group

The early phase oncology group at Imclone is seeking a physician/scientist with immunology experience to join their team. The Chase Group has been contracted to fulfill the search. For more information about the position, please contact Moira by calling 913.663.3100.

May 19, 2014

TCG Continues Successful Collaboration with AbbVie in Building Their Global Regulatory Group

The Chase Group announces the recruitment of Dr. Steve Engel and Dr. Monique Small as Global Regulatory Leads at AbbVie’s Chicago headquarters. Ken Allison remarked, “Working on these particular searches has been a great experience, and it is our pleasure to present Steve and Monique, extremely...

May 12, 2014

Chase and Lilly Diabetes Come Full Circle

The Chase Group has been retained to identify a diabetes/insulin expert to report into a physician who was recruited by Chase at Lilly over ten years ago! TCG appreciates the continued partnership with Eli Lilly and looks forward to another successful recruitment in the near future.

Apr 17, 2014

Eli Lilly Retains The Chase Group

The search has begun for a thoracic expert to join the medical affairs team at Eli Lilly, and the company has entrusted this focused endeavor to Moira and the team at The Chase Group.

Mar 31, 2014

The Chase Group and Eli Lilly Oncology Business Unit Continue Successful Collaboration

TCG completed another successful recruitment for Eli Lilly with the recent placement of an MD/PhD gastrointestinal expert into their medical affairs organization.

Mar 13, 2014

Isis and The Chase Group Work Together Again

The Chase Group and Isis Pharmaceuticals are working together to recruit an Associate Director/Director of Quality Control. TCG understands the critical importance of finding a scientist with strong management skills for this position.

Mar 7, 2014

Chase Retained to Recruit Clinical Leadership Position in Immunology

Isis Pharmaceuticals has enlisted The Chase Group to fill the Executive Director of Clinical Development, Immunology position. 

Feb 7, 2014

Durata Therapeutics Engages The Chase Group

The Chase Group has been retained by Durata Therapeutics to begin searching for the Vice President of Clinical Development position. TCG welcomes the opportunity to work with this unique biotech company as they look to expand their organization in 2014!

Dec 31, 2013

TCG and Isis Partnership Results in Recruitment of Neurologist

Dr. Roger Lane was successfully recruited by The Chase Group to join Isis Pharmaceuticals as the new Vice President of Clinical Development in Neurology.

Dec 31, 2013

Another Successful Placement at Isis

The Chase Group announces the recruitment of Dr. Andres Digenio to their Executive Director of Clinical Development, Cardiology/Metabolic position at Isis Pharmaceuticals.